- Home
- ECF vs THTX Comparison
ECF vs THTX Comparison
Compare ECF & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECF
- THTX
- Stock Information
- Founded
- ECF 1986
- THTX 1993
- Country
- ECF United States
- THTX Canada
- Employees
- ECF N/A
- THTX N/A
- Industry
- ECF Finance/Investors Services
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- ECF Finance
- THTX Health Care
- Exchange
- ECF Nasdaq
- THTX Nasdaq
- Market Cap
- ECF 118.6M
- THTX 118.2M
- IPO Year
- ECF N/A
- THTX N/A
- Fundamental
- Price
- ECF $9.77
- THTX $2.61
- Analyst Decision
- ECF
- THTX Hold
- Analyst Count
- ECF 0
- THTX 1
- Target Price
- ECF N/A
- THTX N/A
- AVG Volume (30 Days)
- ECF 57.7K
- THTX 451.9K
- Earning Date
- ECF 01-01-0001
- THTX 07-09-2025
- Dividend Yield
- ECF 6.42%
- THTX N/A
- EPS Growth
- ECF N/A
- THTX N/A
- EPS
- ECF 0.46
- THTX N/A
- Revenue
- ECF N/A
- THTX $88,666,000.00
- Revenue This Year
- ECF N/A
- THTX N/A
- Revenue Next Year
- ECF N/A
- THTX $15.13
- P/E Ratio
- ECF $17.61
- THTX N/A
- Revenue Growth
- ECF N/A
- THTX 13.52
- 52 Week Low
- ECF $7.02
- THTX $1.08
- 52 Week High
- ECF $8.91
- THTX $3.13
- Technical
- Relative Strength Index (RSI)
- ECF 70.94
- THTX 55.99
- Support Level
- ECF $9.69
- THTX $2.48
- Resistance Level
- ECF $9.34
- THTX $2.68
- Average True Range (ATR)
- ECF 0.15
- THTX 0.14
- MACD
- ECF 0.08
- THTX -0.06
- Stochastic Oscillator
- ECF 91.01
- THTX 26.53
About ECF Ellsworth Growth and Income Fund Ltd.
Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.